Kyntra Bio, Inc.
KYNB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000921299
No open-market purchases or sales by Kyntra Bio, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $7.54M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Kyntra Bio, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 100
- −10 vs. Q3 2023
- Shares held
- 70.1M
- +1.74M (+2.5%) vs. Q3 2023
- Total value
- $62.1M
- +$3.15M (+5.3%) vs. Q3 2023
- New holders
- 12
- 33 more added
- Sold out
- 22
- 32 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KYNB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $7.54M |
| Q1 2026 | 32 | $7.01M |
| Q4 2025 | 34 | $10.1M |
| Q3 2025 | 32 | $13.9M |
| Q2 2025 | 30 | $5.62M |
| Q1 2025 | 56 | $10.2M |
| Q4 2024 | 70 | $19.2M |
| Q3 2024 | 72 | $18.3M |
| Q2 2024 | 102 | $50.4M |
| Q1 2024 | 111 | $143.9M |
| Q4 2023 | 100 | $62.1M |
| Q3 2023 | 110 | $59.0M |
| Q2 2023 | 153 | $207.9M |
| Q1 2023 | 173 | $1.42B |
| Q4 2022 | 145 | $1.20B |
| Q3 2022 | 152 | $950.1M |
| Q2 2022 | 152 | $746.9M |
| Q1 2022 | 158 | $816.6M |
| Q4 2021 | 164 | $934.6M |
| Q3 2021 | 165 | $656.8M |
| Q2 2021 | 176 | $1.80B |
| Q1 2021 | 199 | $2.47B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Kyntra Bio, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −519,404−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −161,550−100.0% | Sold out |
| Pinnacle Associates Ltd | 0 | $0 | 0.00% | −143,204−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −109,453−100.0% | Sold out |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −99,940−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −96,451−100.0% | Sold out |
| BHK Investment Advisors, LLC | 0 | $0 | 0.00% | −57,625−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −57,077−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −42,720−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −20,607−100.0% | Sold out |
| Handelsbanken Fonder AB | 0 | $0 | 0.00% | −18,088−100.0% | Sold out |
| Public Employees Retirement Association of Colorado | 0 | $0 | 0.00% | −14,377−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −13,181−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −10,440−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −6,037−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −2,774−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −2,517−100.0% | Sold out |
| Brown Brothers Harriman & Co | 0 | $0 | 0.00% | −2,435−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −104−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −378−100.0% | Sold out |
| Covestor Ltd | 0 | $0 | 0.00% | −39−100.0% | Sold out |